PL378107A1 - 1,2,4-triazyny hamujące HIV - Google Patents

1,2,4-triazyny hamujące HIV

Info

Publication number
PL378107A1
PL378107A1 PL378107A PL37810704A PL378107A1 PL 378107 A1 PL378107 A1 PL 378107A1 PL 378107 A PL378107 A PL 378107A PL 37810704 A PL37810704 A PL 37810704A PL 378107 A1 PL378107 A1 PL 378107A1
Authority
PL
Poland
Prior art keywords
triazines
hiv inhibiting
hiv
inhibiting
medicine
Prior art date
Application number
PL378107A
Other languages
English (en)
Other versions
PL232814B1 (pl
Inventor
Paulus Joannes Lewi
Paul Adrian Jan Janssen
Jonge Marc René De
Lucien Maria Henricus Koymans
Hendrik Maarten Vinkers
Frederik Frans Desiré Daeyaert
Jan Heeres
Ruben Gerardus George Leenders
Georges Joseph Cornelius Hoornaert
Amuri Kilonda
Donald William Ludovici
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of PL378107A1 publication Critical patent/PL378107A1/pl
Publication of PL232814B1 publication Critical patent/PL232814B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075—Two hetero atoms, in positions 3 and 5

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furnace Details (AREA)

Abstract

Przedmiotem niniejszego wynalazku są inhibitory replikacji i HIV o wzorze (I) zdefiniowanym w zgłoszeniu, ich zastosowanie jako leku, sposób ich wytwarzania oraz zawierające je kompozycje farmaceutyczne.
PL378107A 2003-02-07 2004-02-05 Pochodne 1,2,4-triazynowe, ich zastosowanie i zawierająca je kompozycja farmaceutyczna PL232814B1 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP0301289 2003-02-07
WOPCT/EP03/01289 2003-02-07
PCT/EP2004/050084 WO2004074266A1 (en) 2003-02-07 2004-02-05 Hiv inhibiting 1,2,4-triazines

Publications (2)

Publication Number Publication Date
PL378107A1 true PL378107A1 (pl) 2006-03-06
PL232814B1 PL232814B1 (pl) 2019-07-31

Family

ID=32892827

Family Applications (1)

Application Number Title Priority Date Filing Date
PL378107A PL232814B1 (pl) 2003-02-07 2004-02-05 Pochodne 1,2,4-triazynowe, ich zastosowanie i zawierająca je kompozycja farmaceutyczna

Country Status (20)

Country Link
US (1) US7585861B2 (pl)
EP (1) EP1597242B1 (pl)
JP (1) JP4783725B2 (pl)
KR (1) KR20050105190A (pl)
CN (2) CN1747941A (pl)
AP (1) AP2005003365A0 (pl)
AT (1) ATE402152T1 (pl)
AU (1) AU2004213173B2 (pl)
BR (1) BRPI0407306A (pl)
CA (1) CA2513123C (pl)
DE (1) DE602004015254D1 (pl)
EA (1) EA010379B1 (pl)
ES (1) ES2311146T3 (pl)
HR (1) HRP20050690A2 (pl)
IL (1) IL170120A (pl)
MX (1) MXPA05008368A (pl)
NO (1) NO20054127L (pl)
PL (1) PL232814B1 (pl)
WO (1) WO2004074266A1 (pl)
ZA (1) ZA200506254B (pl)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2567574C (en) 2004-04-08 2013-01-08 Targegen, Inc. Benzotriazine inhibitors of kinases
US7923554B2 (en) * 2004-08-10 2011-04-12 Janssen Pharmaceutica N.V. HIV inhibiting 1,2,4-triazin-6-one derivatives
NZ553492A (en) 2004-08-25 2010-11-26 Targegen Inc Triazole derivatives and methods of use
CN101084212A (zh) 2004-09-20 2007-12-05 泽农医药公司 杂环衍生物及其作为硬脂酰CoA去饱和酶介导剂的用途
US7592343B2 (en) 2004-09-20 2009-09-22 Xenon Pharmaceuticals Inc. Pyridazine-piperazine compounds and their use as stearoyl-CoA desaturase inhibitors
EP2289510A1 (en) 2004-09-20 2011-03-02 Xenon Pharmaceuticals Inc. Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes
WO2006034440A2 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
EP2316458A1 (en) 2004-09-20 2011-05-04 Xenon Pharmaceuticals Inc. Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase
MX2007003321A (es) 2004-09-20 2007-06-05 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como agentes terapeuticos.
CN101084207A (zh) 2004-09-20 2007-12-05 泽农医药公司 杂环衍生物及其作为硬脂酰CoA去饱和酶抑制剂的用途
CN101208089A (zh) 2005-06-03 2008-06-25 泽农医药公司 氨基噻唑衍生物作为人硬酯酰-CoA去饱和酶抑制剂
US8133900B2 (en) 2005-11-01 2012-03-13 Targegen, Inc. Use of bi-aryl meta-pyrimidine inhibitors of kinases
US8604042B2 (en) 2005-11-01 2013-12-10 Targegen, Inc. Bi-aryl meta-pyrimidine inhibitors of kinases
PT1951684T (pt) 2005-11-01 2016-10-13 Targegen Inc Inibidores de cinases de tipo biaril-meta-pirimidina
JP2010518014A (ja) * 2007-01-31 2010-05-27 バーテックス ファーマシューティカルズ インコーポレイテッド キナーゼ阻害剤として有用な２−アミノピリジン誘導体
DK2300013T3 (en) 2008-05-21 2017-12-04 Ariad Pharma Inc PHOSPHORUS DERIVATIVES AS KINASE INHIBITORS
MX2011000837A (es) 2008-07-23 2011-04-05 Vertex Pharma Inhibidores de pirazolpiridina cinasa triciclica.
US8569337B2 (en) 2008-07-23 2013-10-29 Vertex Pharmaceuticals Incorporated Tri-cyclic pyrazolopyridine kinase inhibitors
JP2011529062A (ja) 2008-07-23 2011-12-01 バーテックス ファーマシューティカルズ インコーポレイテッド ピラゾロピリジンキナーゼ阻害剤
AU2009279611A1 (en) 2008-08-06 2010-02-11 Vertex Pharmaceuticals Incorporated Aminopyridine kinase inhibitors
CA2760705A1 (en) 2009-05-06 2010-11-11 Vertex Pharmaceuticals Incorporated Pyrazolopyridines
CN102869663A (zh) 2010-01-27 2013-01-09 沃泰克斯药物股份有限公司 吡唑并吡嗪激酶抑制剂
WO2011094290A1 (en) 2010-01-27 2011-08-04 Vertex Pharmaceuticals Incorporated Pyrazolopyrimidine kinase inhibitors
EP2528917B1 (en) 2010-01-27 2016-10-19 Vertex Pharmaceuticals Incorporated Pyrazolopyridines useful for the treatment of autoimmune, inflammatory or (hyper)proliferative diseases
AU2010363329A1 (en) 2010-11-07 2013-05-09 Targegen, Inc. Compositions and methods for treating myelofibrosis
WO2016044445A2 (en) 2014-09-17 2016-03-24 Ironwood Pharmaceuticals, Inc. sGC STIMULATORS
EP4108659A1 (en) 2016-06-07 2022-12-28 Jacobio Pharmaceuticals Co., Ltd. Novel heterocyclic derivatives useful as shp2 inhibitors
AU2018239542C1 (en) 2017-03-23 2021-02-11 Jacobio Pharmaceuticals Co., Ltd. Novel heterocyclic derivatives useful as SHP2 inhibitors
WO2021071984A1 (en) * 2019-10-08 2021-04-15 Skyhawk Therapeutics, Inc. Compounds for modulating splicing
CR20220325A (es) 2019-12-20 2022-08-19 Tenaya Therapeutics Inc Fluoroalquil-oxadiazoles y sus usos
CN111333543B (zh) * 2020-04-17 2022-09-16 武汉工程大学 一种利匹韦林中间体的合成方法
CN115745848A (zh) * 2022-12-07 2023-03-07 上海优合生物科技有限公司 一种氨基胍的加工合成工艺

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3459731A (en) 1966-12-16 1969-08-05 Corn Products Co Cyclodextrin polyethers and their production
CZ154398A3 (cs) 1995-11-23 1998-08-12 Janssen Pharmaceutica N.V. Pevné směsi cyklodextrinů připravené vytlačováním taveniny
NO311614B1 (no) * 1996-10-01 2001-12-17 Janssen Pharmaceutica Nv Substituerte diamino-1,3,5-triazinderivater
DE69909455T2 (de) 1998-03-27 2004-04-15 Lg Life Sciences Ltd. Polyethoxylierte ascorbinsäurederivate als neue antioxidantien und verfahren zu ihrer herstellung
EP0945447A1 (en) * 1998-03-27 1999-09-29 Janssen Pharmaceutica N.V. Trisubstituted 1,3,5-triazine derivatives for treatment of HIV infections
ATE232521T1 (de) * 1998-03-27 2003-02-15 Janssen Pharmaceutica Nv Hiv hemmende pyrimidin derivate
BRPI9915552B8 (pt) * 1998-11-10 2021-05-25 Janssen Pharmaceutica Nv pirimidinas inibidoras da reprodução do hiv
EP1129079B1 (en) * 1998-11-10 2006-01-04 Janssen Pharmaceutica N.V. 2,4-disubstituded triazine derivatives with anti hiv activity
EP1282606B1 (en) * 2000-05-08 2015-04-22 Janssen Pharmaceutica NV Hiv replication inhibiting pyrimidines and triazines
ATE367814T1 (de) 2001-03-15 2007-08-15 Janssen Pharmaceutica Nv Hiv hemmende pyrazinon-derivate
JO3429B1 (ar) * 2001-08-13 2019-10-20 Janssen Pharmaceutica Nv مشتقات برميدينات مثبطة فيروس الايدز

Also Published As

Publication number Publication date
CN102503903A (zh) 2012-06-20
KR20050105190A (ko) 2005-11-03
JP2006516983A (ja) 2006-07-13
HRP20050690A2 (en) 2006-08-31
AP2005003365A0 (en) 2005-09-30
AU2004213173B2 (en) 2010-07-29
EP1597242B1 (en) 2008-07-23
MXPA05008368A (es) 2005-11-04
JP4783725B2 (ja) 2011-09-28
PL232814B1 (pl) 2019-07-31
ZA200506254B (en) 2008-02-27
CA2513123A1 (en) 2004-09-02
NO20054127L (no) 2005-09-05
CA2513123C (en) 2013-04-23
BRPI0407306A (pt) 2006-02-21
AU2004213173A1 (en) 2004-09-02
EA200501268A1 (ru) 2006-02-24
WO2004074266A1 (en) 2004-09-02
EA010379B1 (ru) 2008-08-29
EP1597242A1 (en) 2005-11-23
ES2311146T3 (es) 2009-02-01
ATE402152T1 (de) 2008-08-15
US20070037811A1 (en) 2007-02-15
IL170120A (en) 2013-04-30
DE602004015254D1 (de) 2008-09-04
US7585861B2 (en) 2009-09-08
CN1747941A (zh) 2006-03-15
WO2004074266A8 (en) 2004-11-11

Similar Documents

Publication Publication Date Title
PL378107A1 (pl) 1,2,4-triazyny hamujące HIV
UA100005C2 (ru) Ингибиторы репликации вируса иммунодефицита человека
CY1106788T1 (el) Πυριμιδινες και τριαζινες αναστολης της αντιγραφης του hiv
PL372809A1 (pl) Podstawione pochodne 1,3-difenyloprop-2-en-1-onu,sposób otrzymywania i zastosowanie podstawionych pochodnych 1,3-difenyloprop-2-enu-1-onu
SE0301700D0 (sv) Novel compounds
DE602004008098D1 (de) Substituierte 2h-ä1,2,4ütriazoloä4,3-aüpyrazine als gsk-3-inhibitoren
BR0113838A (pt) Derivados de n-fenil-2-pirimidina-amina
EA200500312A1 (ru) Новые спироконденсированные хиназолиноны и их применение в качестве ингибиторов фосфодиэстераз
SE0101675D0 (sv) Novel composition
GB0114286D0 (en) Nucleoside Derivatives
BRPI0419305B8 (pt) compostos inibidores de p38, composições farmacêuticas compreendendo os mesmos e usos dos referidos compostos na preparação de medicamentos
UY27755A1 (es) Nuevas composiciones farmacéuticas basadas en anticolinérgicos e inhibidores.
GEP20125704B (en) Plk kinase inhibitors
ATE532781T1 (de) 5-(acylamino)indazol-derivate als kinase- inhibitoren
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
ATE372995T1 (de) Benzo(b)(1,4)dioxepinderivate
MX2010002296A (es) Inhibidores iv de polimerasa de fosfadiazina hcv.
MA32776B1 (fr) Inhibiteurs de l'akt et de la p70 s6 kinase
NO20054340L (no) Nye sammenkoplede heterocykler og deres anvendelse
PA8575601A1 (es) Procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso
SE0303541D0 (sv) New compounds
NO20065898L (no) 1-heterocyklyl-1,5-dihydro-pyrido[3,2-b]indol-2-oner
BRPI0509667B8 (pt) composto, processo para a preparação de um composto de fórmula (i), medicamento e uso de um composto
MY134026A (en) ?-carboline derivatives and its pharmaceutical use against depression and anxiety
IL191670A0 (en) Compounds for the inhibition of apoptosis